Olema Oncology

Olema Oncology is a clinical-stage biopharmaceutical company focused on developing therapies for women with cancer, particularly breast cancer. They leverage their deep understanding of endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance to create more effective and convenient treatment options. Their lead investigational asset, palazestrant (OP-1250), is a novel oral compound with combined activity as a complete estrogen receptor antagonist (CERAN) and a selective estrogen receptor degrader (SERD), designed to provide deeper and more durable responses than existing therapies.

Olema has a strong commitment to patient care, with ongoing clinical trials investigating palazestrant both as a monotherapy and in combination with other treatments. They are dedicated to improving outcomes for women with breast cancer and are committed to developing a new generation of targeted therapies for women’s cancers. The company maintains offices in both San Francisco, CA and Cambridge, MA, and emphasizes a collaborative and inclusive culture.

Olema Oncology offers a flexible work environment that allows employees to balance their professional and personal lives. While their offices in San Francisco and Boston are fully open, they have adopted a flexible work model, offering employees allowances to help with their home office and commute. They also provide a flexible time off vacation package, empowering employees to take the time they need to recharge.

Olema Oncology provides a comprehensive benefits package that includes competitive base salary, annual bonus, and stock equity package along with a 401K Match and the option to participate in an Employee Stock Purchase Plan. They also offer a robust health plan for employees and their dependents, including medical, dental, and vision coverage. In addition to these benefits, Olema provides a flexible work model, home office and commute allowances, and a Flexible Time Off Vacation package to allow employees to take the time they need to recharge.

Olema Oncology is a biotechnology company dedicated to developing innovative therapies for women with cancer. They leverage their expertise in endocrine-driven cancers, nuclear receptors, and mechanisms of acquired resistance to create more effective and convenient treatments. Their mission is to transform the standard of care for women living with cancer by focusing on developing therapies that improve patient outcomes and quality of life.

Olema Oncology promotes a collaborative, inclusive, and supportive work environment where individuals are empowered to use their unique skills to make a difference. They prioritize open communication, flexibility, and a commitment to professional development, fostering a sense of belonging and creating a space where employees feel valued and respected.

Olema Oncology is committed to fostering a diverse, equitable, and inclusive workplace where all voices are respected and valued. They believe that a broad range of experiences, backgrounds, and perspectives lead to great ideas and discoveries. Their culture of collaboration, understanding, and inclusion provides equal opportunity for all employees and applicants, with competitive compensation and benefits.